Literature DB >> 34676011

Newly approved IV acetaminophen in Canada: Switching from oral to IV acetaminophen. Is IV worth the price difference? A systematic review.

Maxime Ulrich1,2, Martine Chamberland1, Christel Bertoldi3, Facundo Garcia-Bournissen4, Niina Kleiber5,6,7.   

Abstract

CONTEXT: The use of intravenous acetaminophen leads to meaningful health cost increases for paediatric institutions. Therefore, strict criteria for intravenous acetaminophen administration are needed.
OBJECTIVE: To undertake a systematic review of available evidence comparing oral versus intravenous acetaminophen use in children.
METHOD: A systematic literature search was conducted on five databases. All prospective interventional studies comparing intravenous to oral acetaminophen in patients <18 years old were included. Data collection and analysis were done according to PRISMA guidelines.
RESULTS: Among 6,417 retrieved abstracts, 29 full-text articles were assessed of which 3 were retained. (1) Pharmacokinetic: Oral bioavailability (72% with a high inter-individual variability) was reported in 47 stable patients in a paediatric intensive care unit. (2) Analgesia: In a double-blind randomized controlled trial of 45 children, no difference in analgesia was found between oral and intravenous administration after cleft palate repair. (3) Fever: In an open-label prospective observational study of 200 children, temperature decreased faster after intravenous than oral administration but was similar 4 hours later.
CONCLUSIONS: Available data are insufficient to guide clinicians with a rational choice of route of administration. Oral bioavailability should be studied in paediatric populations outside the intensive care unit. Despite the widespread use of intravenous acetaminophen, there is little evidence to suggest that it improves analgesia compared to the oral formulation. Similarly, fever weans faster but whether this translates into any meaningful clinical outcome is unknown. The lack of data plus the significantly higher costs of intravenous acetaminophen should motivate further research.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Canadian Paediatric Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Acetaminophen; Fever; Paediatrics; Pain; Paracetamol; Pharmacokinetic

Year:  2021        PMID: 34676011      PMCID: PMC8522831          DOI: 10.1093/pch/pxaa137

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  26 in total

1.  A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children.

Authors:  B J Anderson; G A Woollard; N H Holford
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

2.  Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement.

Authors:  Salmaan Kanji; Meghan Hayes; Adam Ling; Larissa Shamseer; Clarence Chant; David J Edwards; Scott Edwards; Mary H H Ensom; David R Foster; Brian Hardy; Tyree H Kiser; Charles la Porte; Jason A Roberts; Rob Shulman; Scott Walker; Sheryl Zelenitsky; David Moher
Journal:  Clin Pharmacokinet       Date:  2015-07       Impact factor: 6.447

3.  Cost Implications of Escalating Intravenous Acetaminophen Use in Children.

Authors:  Florence T Bourgeois; Dionne A Graham; Aaron S Kesselheim; Adrienne G Randolph
Journal:  JAMA Pediatr       Date:  2019-05-01       Impact factor: 16.193

4.  Clinically effective implementation of intravenous paracetamol as primary analgesia after major surgery in neonates and young infants.

Authors:  Manuel A Baarslag; Erwin Ista; Tom de Leeuw; Joost van Rosmalen; Dick Tibboel; Monique van Dijk; Saskia N de Wildt
Journal:  Arch Dis Child       Date:  2018-07-10       Impact factor: 3.791

5.  Healthcare professionals approach paediatric fever in significantly different ways and fever phobia is not just limited to parents.

Authors:  Marta Martins; Francisco Abecasis
Journal:  Acta Paediatr       Date:  2016-04-20       Impact factor: 2.299

6.  Enteral Acetaminophen Bioavailability in Pediatric Intensive Care Patients Determined With an Oral Microtracer and Pharmacokinetic Modeling to Optimize Dosing.

Authors:  Niina Kleiber; Elisa Calvier; Miriam G Mooij; Elke H J Krekels; Wouter H J Vaes; Dick Tibboel; Catherijne A J Knibbe; Saskia N de Wildt
Journal:  Crit Care Med       Date:  2019-12       Impact factor: 7.598

7.  Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children.

Authors:  Scott L Weiss; Mark J Peters; Waleed Alhazzani; Michael S D Agus; Heidi R Flori; David P Inwald; Simon Nadel; Luregn J Schlapbach; Robert C Tasker; Andrew C Argent; Joe Brierley; Joseph Carcillo; Enitan D Carrol; Christopher L Carroll; Ira M Cheifetz; Karen Choong; Jeffry J Cies; Andrea T Cruz; Daniele De Luca; Akash Deep; Saul N Faust; Claudio Flauzino De Oliveira; Mark W Hall; Paul Ishimine; Etienne Javouhey; Koen F M Joosten; Poonam Joshi; Oliver Karam; Martin C J Kneyber; Joris Lemson; Graeme MacLaren; Nilesh M Mehta; Morten Hylander Møller; Christopher J L Newth; Trung C Nguyen; Akira Nishisaki; Mark E Nunnally; Margaret M Parker; Raina M Paul; Adrienne G Randolph; Suchitra Ranjit; Lewis H Romer; Halden F Scott; Lyvonne N Tume; Judy T Verger; Eric A Williams; Joshua Wolf; Hector R Wong; Jerry J Zimmerman; Niranjan Kissoon; Pierre Tissieres
Journal:  Pediatr Crit Care Med       Date:  2020-02       Impact factor: 3.624

Review 8.  Systematic review and meta-analysis of the effects of antipyretic medications on mortality in Streptococcus pneumoniae infections.

Authors:  Sarah Jefferies; Mark Weatherall; Paul Young; Sally Eyers; Richard Beasley
Journal:  Postgrad Med J       Date:  2011-11-25       Impact factor: 2.401

Review 9.  Prophylactic drug management for febrile seizures in children.

Authors:  Martin Offringa; Richard Newton; Martinus A Cozijnsen; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2017-02-22

10.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.

Authors:  David Moher; Larissa Shamseer; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  Syst Rev       Date:  2015-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.